Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The impact of surgery and adjuvant chemotherapy on health‐related quality of life in patients with colon cancer: Changes at group level versus individual level

The impact of surgery and adjuvant chemotherapy on health‐related quality of life in patients... INTRODUCTIONColon cancer is a typical disease of the ageing population. The median age of patients at diagnosis is 67 years (Institute NC, 2019), and due to ageing of the population and the implementation of screening for colorectal cancer, the prevalence of colon cancer will increase (Integraal Kankercentrum Nederland, IKNL, 2020). This will present a challenge in the decision‐making process.Treatment for primary resectable colon cancer consists of surgery and adjuvant chemotherapy for high risk stages II and III patients as indicated by the national guideline (Federatie Medisch specialisten, 2014). Treatment recommendations are based on tumour characteristics and should be weighed against patient characteristics and preferences. Since the beginning of shared decision‐making, it has become increasingly important to consider patient preferences. These preferences also concern the impact of colon cancer treatment on quality of life during and after treatment. Health‐related quality of life (HR‐QoL) is defined as ‘an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns’ (Social Science & Medicine, 1995) and is frequently divided in various domains such as physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning (Aaronson et al., 1993). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

The impact of surgery and adjuvant chemotherapy on health‐related quality of life in patients with colon cancer: Changes at group level versus individual level

Download PDF
8 pages

Loading next page...
 
/lp/wiley/the-impact-of-surgery-and-adjuvant-chemotherapy-on-health-related-OUdBhEFxHD
Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13691
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONColon cancer is a typical disease of the ageing population. The median age of patients at diagnosis is 67 years (Institute NC, 2019), and due to ageing of the population and the implementation of screening for colorectal cancer, the prevalence of colon cancer will increase (Integraal Kankercentrum Nederland, IKNL, 2020). This will present a challenge in the decision‐making process.Treatment for primary resectable colon cancer consists of surgery and adjuvant chemotherapy for high risk stages II and III patients as indicated by the national guideline (Federatie Medisch specialisten, 2014). Treatment recommendations are based on tumour characteristics and should be weighed against patient characteristics and preferences. Since the beginning of shared decision‐making, it has become increasingly important to consider patient preferences. These preferences also concern the impact of colon cancer treatment on quality of life during and after treatment. Health‐related quality of life (HR‐QoL) is defined as ‘an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns’ (Social Science & Medicine, 1995) and is frequently divided in various domains such as physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning (Aaronson et al., 1993).

Journal

European Journal of Cancer Care – Wiley

Published: Nov 1, 2022

Keywords: colon cancer treatment; group level; individual level; quality of life

References

  • The European organization for research and treatment of cancer QLQ‐C30: A quality‐of‐life instrument for use in international clinical trials in oncology
    Aaronson, N. K.; Ahmedzai, S.; Bergman, B.; Bullinger, M.; Cull, A.; Duez, N. J.; Filiberti, A.; Flechtner, H.; Fleishman, S. B.; Haes, J. C. J. M.; Kaasa, S.; Klee, M.; Osoba, D.; Razavi, D.; Rofe, P. B.; Schraub, S.; Sneeuw, K.; Sullivan, M.; Takeda, F.
  • Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study
    Andreis, F.; Ferri, M.; Mazzocchi, M.; Meriggi, F.; Rizzi, A.; Rota, L.; Biasi, B.; Abeni, C.; Codignola, C.; Rozzini, R.; Zaniboni, A.
  • Candidate predictors of health‐related quality of life of colorectal cancer survivors: A systematic review
    Bours, M. J. L.; Linden, B. W. A.; Winkels, R. M.; Duijnhoven, F. J.; Mols, F.; Roekel, E. H.; Kampman, E.; Beijer, S.; Weijenberg, M. P.
  • The effects of physical prehabilitation in elderly patients undergoing colorectal surgery: A systematic review
    Bruns, E. R. J.; Heuvel, B.; Buskens, C. J.; Duijvendijk, P.; Festen, S.; Wassenaar, E. B.; Zaag, E. S.; Bemelman, W. A.; Munster, B. C.
  • Prospective Dutch colorectal cancer cohort: An infrastructure for long‐term observational, prognostic, predictive and (randomized) intervention research
    Burbach, J. P. M.; Kurk, S. A.; Coebergh van den Braak, R. R. J.; Dik, V. K.; May, A. M.; Meijer, G. A.; Punt, C. J. A.; Vink, G. R.; Los, M.; Hoogerbrugge, N.; Huijgens, P. C.; Ijzermans, J. N. M.; Kuipers, E. J.; Noo, M. E.; Pennings, J. P.; Velden, A. M. T.; Verhoef, C.; Siersema, P. D.; Oijen, M. G. H.; Koopman, M.
  • The effect of exercise on cancer‐related cognitive impairment and applications for physical therapy: Systematic review of randomized controlled trials
    Campbell, K. L.; Zadravec, K.; Bland, K. A.; Chesley, E.; Wolf, F.; Janelsins, M. C.
  • Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life
    Cella, D.; Bullinger, M.; Scott, C.; Barofsky, I.
  • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    Charlson, M. E.; Pompei, P.; Ales, K. L.; MacKenzie, C. R.
  • Evidence‐based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30
    Cocks, K.; King, M. T.; Velikova, G.; St‐James, M. M.; Fayers, P. M.; Brown, J. M.
  • Effect of neoadjuvant therapy and rectal surgery on health‐related quality of life in patients with rectal cancer during the first 2 years after diagnosis
    Couwenberg, A. M.; Burbach, J. P. M.; Grevenstein, W. M. U.; Smits, A. B.; Consten, E. C. J.; Schiphorst, A. H. W.; Wijffels, N. A. T.; Heikens, J. T.; Intven, M. P. W.; Verkooijen, H. M.
  • Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: Results from the ColoREctal Well‐being (CREW) cohort study
    Cummings, A.; Grimmett, C.; Calman, L.; Patel, M.; Permyakova, N. V.; Winter, J.; Corner, J.; Din, A.; Fenlon, D.; Richardson, A.; Smith, P. W.; Foster, C.
  • Long‐term functional decline after high‐risk elective colorectal surgery in older adults
    Roo, A. C.; Li, Y.; Abrahamse, P. H.; Regenbogen, S. E.; Suwanabol, P. A.
  • The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta‐analysis of the current literature
    Falleti, M. G.; Sanfilippo, A.; Maruff, P.; Weih, L. A.; Phillips, K. A.
  • Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ‐C30 is robust
    Giesinger, J. M.; Kieffer, J. M.; Fayers, P. M.; Groenvold, M.; Petersen, M. A.; Scott, N. W.; Sprangers, M. A.; Velikova, G.; Aaronson, N. K.
  • Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: A systematic review and Meta‐analysis
    Gillis, C.; Buhler, K.; Bresee, L.; Carli, F.; Gramlich, L.; Culos‐Reed, N.; Sajobi, T. T.; Fenton, T. R.
  • Enhanced recovery program in colorectal surgery: A meta‐analysis of randomized controlled trials
    Greco, M.; Capretti, G.; Beretta, L.; Gemma, M.; Pecorelli, N.; Braga, M.
  • Long‐term changes in physical capacity after colorectal cancer treatment
    Hamaker, M. E.; Prins, M. C.; Schiphorst, A. H.; Tuyl, S. A. C.; Pronk, A.; Bos, F.
  • Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies
    Hamaker, M. E.; Schulkes, K. J.; Bokkel, H. D.; Munster, B. C.; Huis, L. H.; Bos, F.
  • Improving the quality of survivorship for older adults with cancer
    Mohile, S. G.; Hurria, A.; Cohen, H. J.; Rowland, J. H.; Leach, C. R.; Arora, N. K.; Canin, B.; Muss, H. B.; Magnuson, A.; Flannery, M.; Lowenstein, L.; Allore, H. G.; Mustian, K. M.; Demark‐Wahnefried, W.; Extermann, M.; Ferrell, B.; Inouye, S. K.; Studenski, S. A.; Dale, W.
  • Interpretation of changes in health‐related quality of life
    Norman, G. R.; Sloan, J. A.; Wyrwich, K. W.
  • Effects of adjuvant chemotherapy on cognitive function of patients with early‐stage colorectal cancer
    Sales, M. V. C.; Suemoto, C. K.; Apolinario, D.; Serrao, V. T.; Andrade, C. S.; Conceição, D. M.; Amaro, E.; Melo, B. A. R.; Riechelmann, R. P.
  • Enhanced recovery ERAS for elderly: A safe and beneficial pathway in colorectal surgery
    Slieker, J.; Frauche, P.; Jurt, J.; Addor, V.; Blanc, C.; Demartines, N.; Hübner, M.
  • The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization
  • Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: A prospective, longitudinal, controlled study
    Vardy, J. L.; Dhillon, H. M.; Pond, G. R.; Rourke, S. B.; Bekele, T.; Renton, C.; Dodd, A.; Zhang, H.; Beale, P.; Clarke, S.; Tannock, I. F.